...
首页> 外文期刊>Stem cells translational medicine. >Autologous adipose stem cells in treatment of female stress urinary incontinence: Results of a pilot study
【24h】

Autologous adipose stem cells in treatment of female stress urinary incontinence: Results of a pilot study

机译:自体脂肪干细胞治疗女性压力性尿失禁的初步研究结果

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of our study was to find out whether transurethral injections of autologous adipose stem cells (ASCs) are an effective and a safe treatment for female stress urinary incontinence (SUI). We treated five SUI patients with ASCs combined with bovine collagen gel and saline. Prior to the treatment, the ASCs were isolated from subcutaneous fat and expanded for 3 weeks in a good manufacturing practice-level laboratory. The mixture of ASCs and collagen was injected transurethrally via cystoscope. Additionally, viability, multipotency, and surface marker profile of ASCs were analyzed in vitro. We followed up with patients 3, 6, and 12 months after the injections. The primary endpoint was a cough test to measure objectively the effect of the treatment. Validated questionnaires were used to determine the subjective cure rate. After 6 months, 1 of 5 patients displayed a negative cough testwith full bladder filledwith 500 ml of saline. At 1 year, the cough testwas negative with three patients; two of themwere satisfied with the treatment and did notwish further treatment for SUI. Validated questionnaires showed some subjective improvement in all five patients. This is the first study describing the use of autologous ASCs in combination with collagen gel for female SUI treatments. Thus far, the treatment with autologous ASCs has proven safe and well tolerated. However, the feasibility and efficacy of the treatment were not optimal; therefore, additional research is needed to develop SUI injection therapies.
机译:我们研究的目的是确定经尿道注射自体脂肪干细胞(ASC)是否对女性压力性尿失禁(SUI)是有效且安全的治疗方法。我们用ASC联合牛胶原蛋白凝胶和生理盐水治疗了5例SUI患者。在治疗之前,将ASC从皮下脂肪中分离出来,并在良好生产规范水平的实验室中扩增3周。通过膀胱镜经尿道注射ASCs和胶原蛋白的混合物。另外,在体外分析了ASC的生存力,多能性和表面标志物谱。我们在注射后3、6和12个月随访患者。主要终点是咳嗽试验,以客观衡量治疗效果。经验证的问卷用于确定主观治愈率。 6个月后,每5例患者中有1例表现为咳嗽试验阴性,膀胱充满了500 ml盐水。 1年时,3例患者的咳嗽试验为阴性;他们中的两个对治疗感到满意,并且不希望对SUI进行进一步治疗。经验证的问卷调查显示,所有五名患者的主观检查都有改善。这是第一项描述自体ASC与胶原蛋白凝胶联合用于女性SUI治疗的研究。迄今为止,已证明用自体ASC进行治疗是安全且耐受性良好的。但是,该治疗的可行性和疗效不是最佳的。因此,需要更多的研究来开发SUI注射疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号